We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Low-Profile Marker Advances Breast Conservation Therapy

By HospiMedica International staff writers
Posted on 08 Mar 2017
Print article
Image: The BioZorb LP device (Photo courtesy of Focal Therapeutics).
Image: The BioZorb LP device (Photo courtesy of Focal Therapeutics).
A novel bioabsorbable marker implanted during oncoplastic surgery helps delineate the surgical cavity for radiation treatment and long-term monitoring.

The Focal Therapeutics BioZorb low profile (LP) device has a unique three-dimensional (3D) open-spiral design that incorporates six titanium clips placed in a fixed arrangement, providing specific landmarks of the surgical site for treatment planning, delivery, and follow-up. As in the original BioZorb design, the LP model is sutured directly to the tissues surrounding the cavity where the tumor was removed. The bioabsorbable implant dissolves in the body over the course of a year or more, while the titanium marker clips remain in place.

The BioZorb is especially useful when there is no visible residual seroma, a condition encountered during radiation therapy (RT) planning that makes it very difficult to identify the target region. The 3D marker may also assist with patient positioning during treatment, as well as advanced treatment techniques such as image-guided RT and image-based tracking of the lumpectomy site during respiratory motion. The BioZorb LP device, in contrast to the original BioZorb, was designed for use in smaller breasts, in peripheral areas of the breast, and in locations with less surrounding tissue.

“Everyone understands the need for delivering more personalized, targeted and precise medical care. These new designs allow me to offer the BioZorb marker to more of my breast cancer patients,” said Alison Laidley, MD, of Texas Breast Specialists, who was among the first physicians to use BioZorb LP. “Our radiation oncologists who oversee post-surgical radiation treatment have embraced this technology. We have also seen that patients support the idea of minimizing toxicity to surrounding healthy tissues during their radiation treatment.”

Breast conserving therapy (BCT) refers to moderate-dose RT to eradicate any microscopic residual disease left over following breast-conserving surgery. The goals of BCT are to provide the survival equivalent of mastectomy, a cosmetically acceptable breast, and a low rate of recurrence in the treated breast. The success of BCT is also contingent upon moderate-dose RT to eliminate subclinical foci of disease in the ipsilateral breast.

Gold Supplier
Enteral Feeding Pump
Mechanical Ventilator
NKV-550 Series
Vital Signs Monitor
Aurus 20 A
Double-Door Pass-Through Autoclave
150L - 700L Double-Door / Pass-Through

Print article



view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.